Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine
Authors:
- Jack D SobelJSJack D Sobel
- Walter ChaimWCWalter Chaim
- Viji NagappanVNViji Nagappan
- Deborah LeamanDLDeborah Leaman
- 1 November 2003
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 189 (5) , 1297-1300
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida sppAntimicrobial Agents and Chemotherapy, 2002
- Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazoleAmerican Journal of Obstetrics and Gynecology, 2001
- Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infectionsSexually Transmitted Infections, 2001
- Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicansClinical Microbiology Reviews, 1999
- Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerationsAmerican Journal of Obstetrics and Gynecology, 1998
- Treatment of Torulopsis glabrata Vaginitis: Retrospective Review of Boric Acid TherapyClinical Infectious Diseases, 1997
- VaginitisObstetrics & Gynecology, 1995
- Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitisAmerican Journal of Obstetrics and Gynecology, 1995
- Comparativein vitroactivity of antimycotic agents against pathogenic vaginal yeast isolatesMedical Mycology, 1994
- Evolving Pathogens in Vulvovaginal Candidiasis: Implications for Patient CareThe Journal of Clinical Pharmacology, 1992